By Matt Jones
NEW YORK (GenomeWeb News) – Scottish microarray maker Arrayjet and Generation Scotland (GS), a multi-institutional effort to establish infrastructure for discovering the genetic basis of diseases, will collaborate to develop new products and services for identifying biomarkers.
Supported in part by the life sciences funding body Scottish Enterprise, the project will combine Arrayjet's inkjet microarray technology with human biobank material and health data.
Arrayjet CEO Iain McWilliam said in a statement that biomarker discovery is a "key focus area" for the company, and that the collaboration could help "further demonstrate how microarrays can benefit biomarker research using the GS sample resource."
GS is a cross-disciplinary collaboration between five Scottish university medical schools, the Medical Research Council's Human Genetics Unit, the Wellcome Trust Clinical Research Facility, and other partners.